Effects of ITBS Combined with NMES on Dysphagia After Stroke
Effect of ITBS Combined with NMES on Post-stroke Dysphagia and Corresponding Neural Network
1 other identifier
interventional
45
1 country
1
Brief Summary
In recent years, research on intermittent Theta Burst Stimulation (iTBS), as a special high-frequency (repetitive transcranial magnetic stimulation,rTMS) stimulation paradigm, has focused on exploring the effects in healthy people. Based on previous studies, it is believed that the central magnetic stimulation combined with peripheral electrical stimulation based on the "central-peripheral-central" closed-loop rehabilitation concept has the best effect, but there are few clinical studies on the efficacy and mechanism of iTBS combined treatment of dysphagia after stroke, and the selection of the optimal stimulation scheme and target has not yet been determined, therefore, this study aims to observe the efficacy and mechanism of implementation of iTBS combined with neuromuscular electrical stimulation (NMES) on with patients with dysphagia (PSD) .
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Aug 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 11, 2024
CompletedFirst Posted
Study publicly available on registry
June 18, 2024
CompletedStudy Start
First participant enrolled
August 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedSeptember 27, 2024
September 1, 2024
1.2 years
June 11, 2024
September 25, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
functional near-infrared spectroscopy
Functional near-infrared spectroscopy (fNIRS) is a non-invasive neuroimaging technology based on blood vessels, which can be used to evaluate the activation of brain regions associated with swallowing
immediately before and immediately after the intervention
Standardized Swallowing Assessment Scale
The Standard Swallowing Assessment Scale is a method of assessing a patient's swallowing function. During the assessment, the patient's level of consciousness, head and trunk control, breathing patterns, lip closure, soft palate movements, laryngeal function, gag reflex, and voluntary cough should be recorded.The highest score on the scale is 46 points, and the lowest score is 18 points, and the lower the score, the better the swallowing function.
immediately before and immediately after the intervention
The Yale Pharyngeal Residue Severity Rating Scale
The Yale Pharyngeal Residue Severity Rating Scale is a laryngoscopy-based assessment scale used to assess the degree of food residue.The scale divided the residues of the valley of the eglottis and the piriform fossa into grades 1-5 according to the severity of the scale, respectively. The higher the grade, the more severe the food residue
immediately before and immediately after the intervention
Study Arms (3)
iTBS combined with NMES
EXPERIMENTALOn the basis of conventional treatment and swallowing rehabilitation training,The swallowing cortex of the affected hemisphere was stimulated with iTBS first, followed by NMES stimulation for 30 minutes after 10 minutes
iTBS combined with sham NMES
EXPERIMENTALOn the basis of conventional treatment and swallowing rehabilitation training,The swallowing cortex of the affected hemisphere was stimulated with iTBS first, followed by NMES sham stimulation for 30 minutes after 10 minutes
sham iTBS combined with NMES
EXPERIMENTALOn the basis of conventional treatment and swallowing rehabilitation training,The swallowing cortex of the affected hemisphere was stimulated with sham iTBS first, followed by NMES stimulation for 30 minutes after 10 minutes
Interventions
The treatment parameter for iTBS was 80% stimulus intensity. The stimulation frequency was 50Hz in the plexus and 5Hz in the interplexus. Each burst stimulus consisted of 3 consecutive pulses, 2s stimulus, 8s interval, and repeated 20 times, a total of 600 pulses, and the duration of stimulation was 189s. NMES treatment parameters for output waveform for two-way square wave, wave width 700 ms, positive and negative half wave (300 ms) between 100 ms intermittent, stimulating frequency 50 hz, treatment when the output intensity range of 0 \~ 25 ma, stimulating electrodes pasted in bilateral mandibular hyoid muscle movement points, output intensity in patients with tongue bone muscle group it is advisable to have a sense of fashion, extrusion. Each treatment lasted 30 minutes, once a day, 5 times a week for 2 weeks.
Eligibility Criteria
You may qualify if:
- \~80 years old;
- The patients met the diagnostic criteria of stroke in the "Diagnostic Points for Major Cerebrovascular Diseases in China 2019" formulated by the Chinese Society of Neurology, and were confirmed by head CT or MRI;
- The patients met the diagnostic criteria of dysphagia in the "Chinese Expert Consensus on the Evaluation and treatment of Dysphagia (2017 edition)" and were confirmed by VFSS;
- The disease duration ranged from 2 weeks to 6 months;
- The vital signs of the patient were stable;
- The score of mini-mental state examination (MMSE) was more than 17 points for the illiterate, more than 20 points for the primary scholar, and more than 24 points for the secondary school or above;
- Can independently or under the auxiliary balance the seat 30 minutes or more;
- The skull was intact without craniotomy and/or cranioplasty;
- Informed consent was obtained from all subjects or their families.
You may not qualify if:
- A history of other diseases that may cause dysphagia, such as Parkinson's disease, head and neck radiotherapy, or other neurological diseases;
- Contraindications to iTBS or NMES with a history of epilepsy, intracranial metal implants, bleeding tendency, etc.;
- Skin damage and infection on the front of the neck affect the placement of the surface electrode;
- Such as fever, important viscera function failure condition is not stable, or critically ill.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450044, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
June 11, 2024
First Posted
June 18, 2024
Study Start
August 3, 2024
Primary Completion
November 1, 2025
Study Completion
December 1, 2025
Last Updated
September 27, 2024
Record last verified: 2024-09
Data Sharing
- IPD Sharing
- Will not share